Bayer is now going to conduct Phase 3 clinical trials for obstructive HCM in Japan, while Cytokinetics will expand its ongoing ACACIA-HCM and CEDAR-HCM trials into Japan.
Lackluster Support for Ridwan Kamil in Jakarta Ridwan Kamil’s electability remains stagnant in the Jakarta regional head election. His supporting parties are not actively campaigning for him, leaving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback